Alkem Imperia Online Quiz - June'2018
Alkem Imperia
- 1.Dose of Dabiclot in patients with creatinine clearance 15-30ml/min will be:
- A.
150mg BID
- B.
110mg BID
- C.
75mg BID
- D.
Not recommended
- 2.Why will a dr prefer Dabiclot over other brands of Dabigatran
- A.
Innovative manufacturing process to overcome technical challenges
- B.
HPMC capsule shell
- C.
Bioequivalence study compared with US Innovator
- D.
All of the above
- 3.Dabiclot 110mg reduces risk of intracranial bleeding over Warfarin by what percent:
- A.
69%
- B.
65%
- C.
60%
- D.
55%
- 4.RELYABLE trial was an extension of RELY trail for how many years:
- A.
4 years
- B.
6 years
- C.
2.3 years
- D.
1 year
- 5.Dabiclot reduces the risk of first stroke or systemic embolism over warfarin by:
- A.
20%
- B.
25%
- C.
30%
- D.
35%
- 6.What is HPMC?
- A.
Hydroxy Pentyl Mono Cellulose
- B.
Hydroxy Propyl Methyl Cellulose
- C.
Hydro Propane Methane Cellulose
- D.
None of the above
- 7.What is MUPS technology?
- A.
Multiple Particulate technology
- B.
Multi Unit Particulate System technology
- C.
Multi Para System technology
- D.
None of the above
- 8.What is the quantity of JAPI reprints received per ME?
- A.
20
- B.
40
- C.
30
- D.
60
- 9.What is the quantity of Business Desk Lamp received per ME?
- A.
20
- B.
40
- C.
30
- D.
10
- 10.Clot Case Series Issue 6 talks about which of the following topics:
- A.
Use of Dabigatran in patient not responding to Warfarin
- B.
Use of Dabigatran in a non anti coagulated patient determined on basis of CHADSVASc Score
- C.
Use of Dabigatran in patient with AF on antiplatelet therapy
- D.
None of the above
- 11.The special input (Business desk Lamp) will be given on priority to which set of drs:
- A.
RM/DSM adopted drs
- B.
20 drs selected for effort driven conversion for Dabiclot
- C.
10 drs selected for Ezuric/Muzika
- D.
Any dr out of 60
- 12.Dabiclot brand reminder input for the month of May was:
- A.
Dabiclot paper weight
- B.
Dabiclot Chit pad
- C.
Dabiclot Rx pad
- D.
None of the above
- 13.Muzika is indicated in which class of patients:
- A.
NYHA Class I
- B.
NYHA Class II
- C.
NYHA Class III
- D.
NYHA Class III – IV
- 14.Ezuric is indicated in which class of patients:
- A.
NYHA Class I
- B.
NYHA Class II
- C.
NYHA Class III
- D.
NYHA Class II – IV
- 15.Ezuric/Muzika is being promoted to how many doctors?
- A.
5
- B.
10
- C.
15
- D.
20
- 16.Chemist availability for Ezuric/Muzika is to be done at how many retailers?
- A.
10
- B.
20
- C.
30
- D.
40
- 17.Which competitor brand(s) will you focus on for conversion to Ezuric?
- A.
Isodac
- B.
Eptus
- C.
Planep
- D.
Both b & c are true
- 18.Which competitor brand will you focus on for conversion to Muzika?
- A.
Isolazine
- B.
Isoflav
- C.
Isodac
- D.
Isoniazid
- 19.In case of the Drs being targeted for Ezuric and Muzika, which brand will be promoted first?
- A.
Dabiclot
- B.
Ezuric
- C.
Muzika
- D.
Any of the above
- 20.What are the competitors of Dabiclot?
- A.
Pradaxa
- B.
Dabistar
- C.
Dabigat
- D.
All options are true
Questions: 10 | Attempts: 4018 | Last updated: Mar 21, 2022
-
Sample QuestionThe causative agents of bronchiolitis include all of the following except
Questions: 20 | Attempts: 1264 | Last updated: Mar 20, 2022
-
Sample QuestionArea manager job before he moves to TE Territory is to do
Questions: 20 | Attempts: 700 | Last updated: Mar 20, 2022
-
Sample QuestionThe subscription cost for JobAlert SL is Le.250 per delivery
Back to top